Elonva不會造成自體免疫反應

Elonva活產率約21%
Elonva不會造成自體免疫反應

http://humrep.oxfordjournals.org/content/26/8/2200.full?sid=cc9d9992-57cb-4201-96ce-9c7046dbffd2

Table IV

For fresh cycles only: pregnancy rates per started cycle and implantation rates per embryo transfer.

	Treatment cycle
	Cycle 1 (N = 682)	Cycle 2 (N = 375)	Cycle 3 (N = 198)
Biochemical pregnancy (%)a	31.4	28.5	27.8
Clinical pregnancy (%)b	26.2	23.5	24.2
Vital pregnancy (%)c	23.0	21.3	21.2
Ongoing pregnancy (%)d	22.7	20.5	20.7
Singletons	81.9	83.1	87.8
Twins	16.8	16.9	12.2
Triplets	1.3	1.3	0
Implantation rate, % (ne)	21.2 (n = 616)	16.6 (n = 340)	16.3 (n = 178)